fluorodeoxyglucose f18 has been researched along with Drug Refractory Epilepsy in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 18 (48.65) | 24.3611 |
| 2020's | 19 (51.35) | 2.80 |
| Authors | Studies |
|---|---|
| Bender, D; Beniczky, S; Brooks, DJ; Christensen, J; Dietz, MJ; Højlund, A; Jacobsen, J; Møller, A; Vibholm, AK | 1 |
| Aygun, N; Dickson, J; Duncan, JS; Holtkamp, M; Ilyas-Feldmann, M; Menon, RN; Radhakrishnan, A; Rathore, C; Steinbrenner, M; Wächter, B | 1 |
| Dahmoush, HM; Khalaf, AM; Nadel, HR | 1 |
| Berkovic, SF; Cahill, V; Chen, Z; Desmond, PM; Fabinyi, GC; Hicks, RJ; Kaye, AH; King, JA; Kitchen, A; Kwan, P; Law, M; Malpas, CB; Morokoff, AP; O'Brien, TJ; O'Shea, MF; Seah, J; Sinclair, B; Vivash, LE | 1 |
| Aparicio, J; Campistol, J; Candela-Cantó, S; Muchart, J; Niñerola-Baizán, A; Perissinotti, A; Rubí, S; Setoain, X | 1 |
| Aslam, S; Damodaran, N; Gopinath, S; Pillai, A; Rajeshkannan, R; Sarma, M | 1 |
| Antonic-Baker, A; Courtney, MR; Kwan, P; Law, M; Neal, A; Nicolo, JP; O'Brien, TJ; Sinclair, B; Vivash, L | 1 |
| Buraniqi, E; Guerin, JB; Krecke, K; Miller, KJ; Nickels, KC; Payne, ET; Van Gompel, JJ; Wirrell, EC; Wong-Kisiel, L | 1 |
| Kim, SJ; Koo, YS; Lee, SA; Nam, H | 1 |
| Bouvard, S; Costes, N; Flaus, A; Guénot, M; Hammers, A; Janier, M; Jung, J; Lartizien, C; Ostrowky-Coste, K; Rheims, S; Yaakub, SN | 1 |
| Besson, FL; Bottlaender, M; Bouilleret, V; Caillé, F; Cheval, M; Leroy, C; Petrescu, AM; Rodrigo, S; Taussig, D; Tournier, N | 1 |
| Avendaño-Estrada, A; Ávila-Rodríguez, MA; Cuellar-Herrera, M; Marquez-Franco, R; Rivera-Bravo, B; Saucedo-Alvarado, PE; Velasco, AL; Velasco, F | 1 |
| Cardinale, F; Ciampi, E; Di Giacomo, R; Gozzo, F; Mai, R; Mariani, V; Onofrj, M; Pelliccia, V; Tassi, L; Uribe San Martin, R | 1 |
| Federico, P; Gnanakumar, R; Josephson, CB; Molnar, CP; Numerow, LM; Peedicail, JS; Pillay, N; Scott, J; Singh, S; Wiebe, S | 1 |
| Brown, MG; Davis, KA; Dubroff, JG; Hadar, PN; Kini, LG; Shinohara, RT; Thaker, AA | 1 |
| Bonilha, L | 1 |
| Anazodo, UC; Burneo, JG; Iacobelli, M; Jurkiewicz, MT; Kwan, BYM; Lam Shin Cheung, V; Moran, G; Poirier, SE; Prato, FS; Samargandy, L; Steven, DA; Thiessen, JD; Thompson, RT | 1 |
| Aghakhani, N; Bouilleret, V; Chipaux, M; Dorfmüller, G; Ferrand-Sorbets, S; Fohlen, M; Herbrecht, A; Petrescu, AM; Rodrigo, S; Taussig, D | 1 |
| Bund, C; Hirsch, E; Hirsch, MPV; Namer, IJ; Ollivier, I | 1 |
| Castiñeira-Mourenza, JA; Martínez-Pías, E; Prieto-González, AJ; Rodríguez-Osorio, X | 1 |
| Ben, J; de Oliveira Thais, MER; de Paula Martins, R; Hoeller, AA; Latini, A; Leal, RB; Lin, K; Linhares, MN; Lopes, MW; Markowitsch, HJ; Osório, CM; Prediger, RD; Remor, AP; Vascouto, HD; Walz, R; Wolf, P | 1 |
| Ahmed, R; Carter Snead, O; Drake, JM; Go, C; Rubinger, L; Rutka, JT; Widjaja, E | 1 |
| Barnes, A; De Blasi, B; Galazzo, IB; Hua, CH; Koepp, M; Shulkin, B; Tisdall, M | 1 |
| Allen, V; Dudley, R; Handler, M; Laoprasert, P; Mirsky, D; O'Neill, B; Schur, S; Stence, N; White, A | 1 |
| Behen, ME; Chugani, HT; Govil-Dalela, T; Juhász, C; Kumar, A | 1 |
| Baillés, E; Bargalló, N; Boget, T; Carreño, M; Donaire, A; Mané, A; Pintor, L; Ramos-Perdigués, S; Rumià, J; Setoain, X; Valdés, M | 1 |
| Han, CL; Hu, W; Liu, TH; Meng, FG; Wang, F; Wang, KL; Xia, XT; Zhang, JG; Zhao, XB | 1 |
| Cho, H; Kang, HC; Kim, DS; Kim, HD; Ko, A; Lee, JS; Oh, MK; Pae, C; Park, EK; Park, HJ; Shim, KW; Yu, R | 1 |
| Berkovic, SF; Berlangieri, SU; Cahill, V; Chen, Z; Desmond, PM; Fabinyi, GC; Hicks, RJ; Kaye, AH; King, JA; Kwan, P; Malpas, CB; McIntosh, AM; Morokoff, AP; O'Brien, TJ; O'Shea, MF; Rowe, CC; Sinclair, B; Vivash, LE; Wilson, SJ | 1 |
| Hirsch, E; Montaz-Rosset, MS; Namer, IJ; Scholly, J; Severac, F; Valenti-Hirsch, MP; Voulleminot, P | 1 |
| Abraham, M; Kesavadas, C; Menon, RN; Parameswaran, R; Radhakrishnan, A; Sarma, SP; Thomas, B; Vilanilam, G | 1 |
| Arihiro, K; Awai, K; Higaki, T; Hirokawa, Y; Iida, K; Kaichi, Y; Kakita, A; Komoto, D; Takauchi, K | 1 |
| Chang, BL; Chang, CW; Cheng, MY; Chiang, HI; Hsieh, HY; Lee, CH; Lee, CY; Lee, ST; Lim, SN; Tseng, WE; Tu, PH; Wu, T | 1 |
| Barnes, A; Bomanji, JB; Boscolo Galazzo, I; De Vita, E; Duncan, JS; Fraioli, F; Golay, X; Groves, AM; Jäger, HR; Koepp, M; Mattoli, MV; Pizzini, FB | 1 |
| Bargalló, N; Boget, T; Carrasco, JL; Carreño, M; Donaire, A; Lomeña, F; Marti-Fuster, B; Mayoral, M; Perissinotti, A; Pintor, L; Rumià, J; Setoain, X | 1 |
| Iwasaki, M; Jin, K; Mugikura, S; Nakasato, N; Sato, S; Suzuki, H; Takahashi, S; Takase, K; Tominaga, T | 1 |
| Jain, A; Seniaray, N | 1 |
37 other study(ies) available for fluorodeoxyglucose f18 and Drug Refractory Epilepsy
| Article | Year |
|---|---|
Activated N-methyl-D-aspartate receptor ion channels detected in focal epilepsy with [
Topics: Brain; Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Epilepsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Receptors, N-Methyl-D-Aspartate | 2021 |
Utility of 18F-fluorodeoxyglucose positron emission tomography in presurgical evaluation of patients with epilepsy: A multicenter study.
Topics: Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Retrospective Studies; Seizures | 2022 |
Simultaneously Acquired MRI Arterial Spin-Labeling and Interictal FDG-PET Improves Diagnosis of Pediatric Temporal Lobe Epilepsy.
Topics: Child; Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Epilepsy; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Retrospective Studies; Seizures; Spin Labels | 2022 |
Machine learning approaches for imaging-based prognostication of the outcome of surgery for mesial temporal lobe epilepsy.
Topics: Drug Resistant Epilepsy; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Humans; Machine Learning; Magnetic Resonance Imaging; Seizures; Treatment Outcome | 2022 |
Presurgical evaluation of drug-resistant paediatric focal epilepsy with PISCOM compared to SISCOM and FDG-PET.
Topics: Child; Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Epilepsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Quality of Life; Tomography, Emission-Computed, Single-Photon | 2022 |
Asymmetry index in anatomically symmetrized FDG-PET for improved epileptogenic focus detection in pharmacoresistant epilepsy.
Topics: Adolescent; Adult; Cerebral Cortex; Child; Drug Resistant Epilepsy; Electroencephalography; Epilepsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Pilot Projects; Positron-Emission Tomography; Young Adult | 2023 |
Topics: Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Epilepsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Meta-Analysis as Topic; Positron-Emission Tomography; Systematic Reviews as Topic | 2022 |
Temporal Encephalocele: A Treatable Etiology of Drug-Resistant Pediatric Temporal Lobe Epilepsy.
Topics: Adolescent; Adult; Child; Drug Resistant Epilepsy; Encephalocele; Epilepsy; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Temporal Lobe; Treatment Outcome | 2023 |
Accuracy of predicting surgical outcomes using interictal electrical source imaging in patients with MRI-negative intractable epilepsy.
Topics: Drug Resistant Epilepsy; Electroencephalography; Epilepsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome | 2023 |
Deep-learning predicted PET can be subtracted from the true clinical fluorodeoxyglucose PET co-registered to MRI to identify the epileptogenic zone in focal epilepsy.
Topics: Deep Learning; Drug Resistant Epilepsy; Epilepsy; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography | 2023 |
[
Topics: Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Receptors, GABA | 2023 |
Quantitative Analysis of [18F]FFMZ and [18F]FDG PET Studies in the Localization of Seizure Onset Zone in Drug-Resistant Temporal Lobe Epilepsy.
Topics: Adolescent; Adult; Brain Mapping; Drug Resistant Epilepsy; Epilepsy, Temporal Lobe; Female; Flumazenil; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Seizures | 2019 |
Forecasting Seizure Freedom After Epilepsy Surgery Assessing Concordance Between Noninvasive and StereoEEG Findings.
Topics: Adolescent; Adult; Child; Cohort Studies; Drug Resistant Epilepsy; Electroencephalography; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Retrospective Studies; Seizures; Treatment Outcome; Young Adult | 2020 |
Impact of ictal subtraction SPECT and PET in presurgical evaluation.
Topics: Adolescent; Adult; Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Intraoperative Neurophysiological Monitoring; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron Emission Tomography Computed Tomography; Prognosis; Retrospective Studies; Surgery, Computer-Assisted; Tomography, Emission-Computed, Single-Photon | 2021 |
Quantitative
Topics: Drug Resistant Epilepsy; Electroencephalography; Epilepsy, Temporal Lobe; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Retrospective Studies; Seizures; Treatment Outcome | 2021 |
Artificial intelligence to enhance the evaluation of refractory epilepsies.
Topics: Artificial Intelligence; Drug Resistant Epilepsy; Epilepsies, Partial; Fluorodeoxyglucose F18; Humans; Seizures | 2021 |
An evaluation of the diagnostic equivalence of
Topics: Drug Resistant Epilepsy; Epilepsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Pharmaceutical Preparations; Pilot Projects; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography | 2021 |
Topics: Drug Resistant Epilepsy; Electroencephalography; Epilepsy; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Seizures | 2021 |
Three Different FDG Patterns in Periventricular Nodular Heterotopia Correlated to Video Stereoelectroencephalography.
Topics: Adult; Drug Resistant Epilepsy; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Periventricular Nodular Heterotopia; Positron-Emission Tomography | 2021 |
[Temporal pole encephalocele, a surgical treatable cause of drug-resistant epilepsy].
Topics: Adult; Drug Resistant Epilepsy; Electroencephalography; Encephalocele; Epilepsies, Partial; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2021 |
Neuropsychological functioning and brain energetics of drug resistant mesial temporal lobe epilepsy patients.
Topics: Adult; Anticonvulsants; Brain; Drug Resistant Epilepsy; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Multienzyme Complexes; Neuropsychological Tests; Positron-Emission Tomography; Statistics, Nonparametric | 2017 |
Utility of additional dedicated high-resolution 3T MRI in children with medically refractory focal epilepsy.
Topics: Brain; Child; Drug Resistant Epilepsy; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Magnetoencephalography; Male; Malformations of Cortical Development; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Seizures; Sensitivity and Specificity; Treatment Outcome | 2018 |
Age-Specific
Topics: Adolescent; Age Factors; Case-Control Studies; Child; Drug Resistant Epilepsy; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Precision Medicine; Retrospective Studies | 2018 |
Significance of FDG-PET Hypermetabolism in Children with Intractable Focal Epilepsy.
Topics: Child; Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Hemispherectomy; Humans; Male; Positron-Emission Tomography; Retrospective Studies | 2018 |
Evolution of lobar abnormalities of cerebral glucose metabolism in 41 children with drug-resistant epilepsy.
Topics: Adolescent; Anticonvulsants; Blood Glucose; Brain; Child; Child, Preschool; Developmental Disabilities; Disease Progression; Dominance, Cerebral; Drug Resistant Epilepsy; Electroencephalography; Energy Metabolism; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Infant; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Retrospective Studies | 2018 |
Psychiatric Symptoms in Refractory Epilepsy During the First Year After Surgery.
Topics: Adult; Drug Resistant Epilepsy; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Disorders; Middle Aged; Neuropsychological Tests; Neurosurgical Procedures; Positron-Emission Tomography; Postoperative Complications; Prospective Studies; Psychiatric Status Rating Scales; Retrospective Studies | 2018 |
Metabolic covariance networks combining graph theory measuring aberrant topological patterns in mesial temporal lobe epilepsy.
Topics: Adolescent; Adult; Brain; Drug Resistant Epilepsy; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neural Pathways; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Young Adult | 2019 |
Interregional metabolic connectivity of 2-deoxy-2[
Topics: Adolescent; Adult; Brain Chemistry; Child; Cross-Sectional Studies; Drug Resistant Epilepsy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Metabolic Networks and Pathways; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Seizures; Treatment Outcome; Vagus Nerve Stimulation; Young Adult | 2018 |
Metabolic patterns and seizure outcomes following anterior temporal lobectomy.
Topics: Adult; Anterior Temporal Lobectomy; Case-Control Studies; Drug Resistant Epilepsy; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Sclerosis; Treatment Outcome | 2019 |
Comparison of Functional Deficit Zone Defined by FDG PET to the Epileptogenic Zones Described in Stereo-Electroencephalograph in Drug-Resistant Epileptic Patients Treated by Surgery.
Topics: Adolescent; Adult; Brain Mapping; Child; Child, Preschool; Drug Resistant Epilepsy; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals | 2019 |
Does F-18 FDG-PET substantially alter the surgical decision-making in drug-resistant partial epilepsy?
Topics: Adolescent; Adult; Child; Child, Preschool; Decision Making; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Seizures; Young Adult | 2015 |
Diagnostic Performance of Positron Emission Tomography for the Presurgical Evaluation of Patients with Non-lesional Intractable Partial Epilepsy: Comparison among 18F-FDG, 11C-Flumazenil, and 11C-Flumazenil Binding Potential Imaging Using Statistical Imag
Topics: Adolescent; Adult; Brain; Brain Mapping; Brain Waves; Carbon Radioisotopes; Case-Control Studies; Data Interpretation, Statistical; Drug Resistant Epilepsy; Electroencephalography; Epilepsies, Partial; Female; Flumazenil; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Magnetoencephalography; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Young Adult | 2015 |
Low and High Frequency Hippocampal Stimulation for Drug-Resistant Mesial Temporal Lobe Epilepsy.
Topics: Adult; Anticonvulsants; Biophysics; Deep Brain Stimulation; Drug Resistant Epilepsy; Electroencephalography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Video Recording | 2016 |
Cerebral metabolism and perfusion in MR-negative individuals with refractory focal epilepsy assessed by simultaneous acquisition of (18)F-FDG PET and arterial spin labeling.
Topics: Adult; Brain Mapping; Cerebrovascular Circulation; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Severity of Illness Index; Spin Labels | 2016 |
Seizure-onset zone localization by statistical parametric mapping in visually normal (18) F-FDG PET studies.
Topics: Adult; Brain Mapping; Cerebral Cortex; Drug Resistant Epilepsy; Electroencephalography; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2016 |
T2 relaxometry improves detection of non-sclerotic epileptogenic hippocampus.
Topics: Adolescent; Adult; Atrophy; Drug Resistant Epilepsy; Electrocorticography; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Sclerosis; Young Adult | 2016 |
PET MRI Coregistration in Intractable Epilepsy and Gray Matter Heterotopia.
Topics: Adult; Drug Resistant Epilepsy; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals | 2017 |